Skip to content

Thromboinflammation in cardiovascular diseases

According to the World Health Organisation, cardiovascular diseases are the most common cause of death worldwide. If the finely-tuned cell mechanisms in the vascular system of the body are disrupted, this can promote inflammation and blood coagulation (thromboses). The European joint project »Thromboinflammation in cardiovascular diseases« (TICARDIO) combines the investigations into these two pathological processes for the first time under the heading “Thromboinflammation”. This project focusses on the interaction between the vessel wall and blood, which has a key role to play in the abnormal processes in cardiovascular disease. The aim is to find new target molecules (targets) for active pharmaceutical ingredients and specific diagnostic markers.

Inhibiting and activating paths of blood platelets in thrombosis The endothelial cells produce substances that line the inside of blood vessels and inhibit or activate the thrombocytes. The »TICARDIO« subproject »Endothelial-derived inhibiting and activating pathways of platelets in thrombosis« at ISAS addresses the role this plays in the emergence of thrombosis. A phospho-targeted mass spectrometry-based assay is being used in order, for example, to investigate the key mediators of the inhibiting and activating paths of the thrombocytes. During the course of the project, it has been possible to identify the tyrosine-protein kinase Syk as key mediator, and also verify the total Syk protein and three different phosphorylated points. Phosphorylation, the reversible attachment of a phosphate group, plays an important role in the transmission of cellular signals. The analysis therefore enables conclusions to be drawn about how thrombocytes are inhibited and activated. A further aim is to characterise the variants of the phosphorylation points using ion mobility spectrometry.

About TICARDIO

TICARDIO is an international study which promotes the interdisciplinary training of postgraduates. It offers 15 doctoral candidates of the natural sciences a route to obtaining a European Joint Doctorate. The participants also benefit from the multi-disciplinary and intersectoral collaboration of all organisations involved. The Center for Thrombosis and Haemostasis (CTH) at the University Medical Center in Mainz coordinates the network of doctoral candidates.

Share

Select publications

Journal of Biological Chemistry, Vol. 300, No. 12, 2024

Zou J, Zhang P, Solari F, Schönichen C, Provenzale I, Mattheij NJA, Kuijpers MJE, Rauch JS, Swieringa F, Sickmann A, Zieger B, Jurk K, Heemskerk JW.

Suppressed ORAI1-STIM1-dependent Ca2+ entry by protein kinase C isoforms regulating platelet procoagulant activity

https://doi.org/10.1016/j.jbc.2024.107899

Thrombosis and Haemostasis, Vol. 125, No. 5, 2024, P. 470-483

Zhang P, von Ungern-Sternberg S, Hastenplug L, Solari F, Sickmann A, Kuijpers M, Heemskerk JW, Walter U, Jurk K.

Multi-phased kinetics and interaction of protein kinase signaling in glycoprotein VI-induced platelet αIIbβ3 integrin activation and degranulation

https://doi.org/10.1055/a-2311-0117

FASEB Journal, Vol. 38, No. 4, 2024, P. e23468

Provenzale I, Solari FA, Schönichen C, Brouns SLN, Fernández DI, Kuijpers MJE, van der Meijden PEJ, Gibbins JM, Sickmann A, Jones C, Heemskerk JWM.

Endothelium-mediated regulation of platelet activation: Involvement of multiple protein kinases

https://doi.org/10.1096/fj.202300360RR

Thrombosis and Haemostasis, Vol. 123, No. 8, 2023, P. 808-839

Akbulut AC, Arisz RA, Baaten CCFMJ, Baidildinova G, Barakzie A, Bauersachs R, Ten Berg J, van den Broek WWA, de Boer HC, Bonifay A, Bröker V, Buka…

Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis

https://doi.org/10.1055/a-2052-9175

International Journal of Molecular Sciences, Vol. 24, No. 9, 2023

Zhang P, Solari F, Heemskerk JW, Kuijpers MJE, Sickmann A, Walter U, Jurk K.

Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets

https://doi.org/10.3390/ijms24097776

Blood, Vol. 139, No. 17, 2022, P. 2691-2705

Leberzammer J, Agten SM, Blanchet X, Duan R, Ippel H, Megens RTA, Schulz C, Aslani M, Duchene J, Doring Y, Jooss NJ, Zhang P, Brandl R, Stark K,…

Targeting platelet-derived CXCL12 impedes arterial thrombosis

https://doi.org/10.1182/blood.2020010140

International Journal of Molecular Sciences, Vol. 22, No. 18, 2021

Huang J, Zhang P, Solari FA, Sickmann A, Garcia A, Jurk K, Heemskerk JWM.

Molecular Proteomics and Signalling of Human Platelets in Health and Disease

https://doi.org/10.3390/ijms22189860

Further projects

New Research Training Group of Essen University Medical Centre & ISAS is Dedicated to Consequential Injury Following a Heart Attack

When blood starts flowing again after a heart attack, it can literally flood the affected heart muscle cells with oxygen and nutrients and thus cause secondary damage. The DFG-funded research training group ‘TCI repAMI’ at the University Hospital Essen and ISAS is investigating how immune cells, blood vessel cells and heart muscle cells interact in this process. Clinical and research experts are working together in tandem teams in eleven sub-projects to provide interdisciplinary training for a total of 33 doctoral students.

B2B-RARE – Bench to Bedside: Therapies for Individuals with Hereditary Muscle Disorders

An interdisciplinary consortium of researchers in North Rhine-Westphalia is dedicated to improving the quality of life of patients with neuromuscular diseases by developing new precision diagnostic and treatment methods. Their goal is to find suitable therapies for patients and bring these directly to their bedsides.

Fast Meat Control (FMC)

The objective of FMC is to develop a mobile measuring instrument which can be used to identify bacteria at meat-processing plants. The hand-held measuring instrument uses a method based on plasma gas chromatography-ion mobility spectrometry (Plasma-GC-IMS).

Optimising Anaemia Treatment for Patients with Chronic Kidney Disease (NephrESA)

In order to treat anaemia more effectively, researchers in the »NephrESA« project are developing a computer model which can be used to determine the risks and prognoses of the medication for each individual affected.